Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
In 2022, Kwang Dong Pharmaceutical posted a net income of around 26.7 billion South Korean won. This represents a slight increase from the previous year. The company is mainly involved with the manufacturing and distribution of pharmaceuticals. Kwang Dong Pharmaceuticals is considered one of
Consolidated net income of Kwang Dong Pharmaceutical Co., Ltd. from 2016 to 2022 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Satisfaction or desire for received pharmaceutical services in the U.S. 2013
- Basic Statistic Top five services from pharma companies for U.S. patients 2013
- Basic Statistic Proactive patients in reviewing select health information and issues 2013
- Basic Statistic Responsibility of pharmaceutical firms to provide complementary services 2013
- Basic Statistic Preferred services from a pharmaceutical company 2013
- Basic Statistic Allocation of R&D investments in pharmaceutical industry by function 2021
- Premium Statistic Growth rate of R&D spending in pharmaceutical industry by major region 2007-2022
- Premium Statistic Production in European pharmaceutical industry by country 2021
- Basic Statistic Employment in European pharmaceutical industry by country 2021
About the region
10
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
Selected statistics
10
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
Other regions
8
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Pharmaceutical products against the spread of COVID-19 in Romanian households 2020
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Main pharmacies in Mexico 2019, by size
- Premium Statistic BCPL net profit FY 2014-2023
Related statistics
10
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2023
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Leading pharmaceutical businesses South Korea 2023, by revenue
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2023
- Premium Statistic Sales revenue Samsung Biologics 2015-2023
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Global sales of the Nestlé Group 2005-2023
- Nestlé Group's sales distribution worldwide 2023, by region
- EBIT margin of the Nestlé Group 2009-2023, by product category
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Global sales of the Nestlé Group 2005-2023
- Nestlé Group's sales distribution worldwide 2023, by region
- EBIT margin of the Nestlé Group 2009-2023, by product category
DART. (March 16, 2023). Consolidated net income of Kwang Dong Pharmaceutical Co., Ltd. from 2016 to 2022 (in billion South Korean won) [Graph]. In Statista. Retrieved May 21, 2024, from https://www.statista.com/statistics/1269741/kwang-dong-pharmaceutical-net-profit/
DART. "Consolidated net income of Kwang Dong Pharmaceutical Co., Ltd. from 2016 to 2022 (in billion South Korean won)." Chart. March 16, 2023. Statista. Accessed May 21, 2024. https://www.statista.com/statistics/1269741/kwang-dong-pharmaceutical-net-profit/
DART. (2023). Consolidated net income of Kwang Dong Pharmaceutical Co., Ltd. from 2016 to 2022 (in billion South Korean won). Statista. Statista Inc.. Accessed: May 21, 2024. https://www.statista.com/statistics/1269741/kwang-dong-pharmaceutical-net-profit/
DART. "Consolidated Net Income of Kwang Dong Pharmaceutical Co., Ltd. from 2016 to 2022 (in Billion South Korean Won)." Statista, Statista Inc., 16 Mar 2023, https://www.statista.com/statistics/1269741/kwang-dong-pharmaceutical-net-profit/
DART, Consolidated net income of Kwang Dong Pharmaceutical Co., Ltd. from 2016 to 2022 (in billion South Korean won) Statista, https://www.statista.com/statistics/1269741/kwang-dong-pharmaceutical-net-profit/ (last visited May 21, 2024)
Consolidated net income of Kwang Dong Pharmaceutical Co., Ltd. from 2016 to 2022 (in billion South Korean won) [Graph], DART, March 16, 2023. [Online]. Available: https://www.statista.com/statistics/1269741/kwang-dong-pharmaceutical-net-profit/